Sex, hormones and neuroeffector mechanisms

Area of Science:

• Cardiovascular Science
• Neuroendocrinology
• Sex Differences in Health

Background:

• Cardiovascular disease (CVD) incidence and rates differ between males and females throughout life.
• While hypertension is more common in males, vasomotor disorders like Raynaud's disease, postural orthostatic tachycardia syndrome, menopausal hot flashes, and migraine exhibit a female predominance.

Purpose of the Study:

• To explore the complex interplay of sex and hormones in modulating neuroeffector mechanisms relevant to cardiovascular control.
• To investigate the influence of sex chromosomes and steroid hormones on autonomic control centers and effector tissues (heart, vascular smooth muscle, endothelium).
• To highlight the emerging role of central serotonergic systems in cardiovascular risk and the need for further research.

Main Methods:

• Review of existing literature on sex differences in cardiovascular disease.
• Analysis of hormonal and genetic influences on neurotransmitter systems and autonomic regulation.
• Examination of the impact of sex hormones on cardiovascular tissues.

Main Results:

• Sex and hormones significantly modulate neuroeffector pathways, including Sry gene regulation and monoamine neurotransmitter systems.
• Sex hormones directly affect neurotransmitter synthesis, release, disposition, and receptor sensitivity in brain autonomic control areas.
• Sex chromosomes and steroids also influence effector tissues such as the heart, vascular smooth muscle, and endothelium.

Conclusions:

• Understanding the sex-specific modulation of neuroeffector mechanisms is crucial for addressing cardiovascular disease disparities.
• Central serotonergic systems warrant further investigation for their contribution to cardiovascular risk in both sexes.
• Future studies should evaluate the effects of hormonal therapies and drugs targeting adrenergic and serotonergic activity on CVD progression in men and women.